The activation of sirtuin, a nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase, is proposed as an innovative therapeutic means, and it plays an important role in inhibiting the progression of insulin resistance in insulin-sensitive tissues along with protecting the pancreatic ß-cells. Here, INS is linked to Insulin resistance.